Haleon plc’s SEC filings document foreign-issuer reports covering capital structure, treasury-share activity, and financing disclosures. Recent Form 6-K reports include transactions in own shares under a buyback programme, ordinary-share and voting-rights totals, and notices used for ownership-notification calculations under FCA disclosure rules.
The filings also cover listing particulars for the Euro Medium Term Note programme of Haleon UK Capital plc and Haleon Netherlands Capital B.V., guaranteed by Haleon. Company descriptions in the reports identify Haleon as a consumer health company with product categories across oral health, vitamins and supplements, pain relief, respiratory health, digestive health, and therapeutic skin health.
Haleon plc reports that it purchased 8,316,688 ordinary shares of £0.01 each for cancellation under its share buyback programme announced on 12 March 2026. The purchases took place between 11 and 15 May 2026 across the London Stock Exchange, CBOE UK venues and Aquis.
After settlement, Haleon’s registered share capital is 8,871,945,578 ordinary shares, of which 12,130,560 are held as treasury shares. The number of ordinary shares with voting rights is now 8,859,815,018, a figure shareholders can use for disclosure threshold calculations under UK transparency rules.
Haleon plc reports that it purchased 8,316,688 ordinary shares of £0.01 each for cancellation under its share buyback programme announced on 12 March 2026. The purchases took place between 11 and 15 May 2026 across the London Stock Exchange, CBOE UK venues and Aquis.
After settlement, Haleon’s registered share capital is 8,871,945,578 ordinary shares, of which 12,130,560 are held as treasury shares. The number of ordinary shares with voting rights is now 8,859,815,018, a figure shareholders can use for disclosure threshold calculations under UK transparency rules.
Haleon plc reported the repurchase of 10,205,329 ordinary shares of £0.01 each for cancellation under its share buyback programme. The purchases took place between 05 May 2026 and 08 May 2026 across the London Stock Exchange, CBOE (UK) venues and Aquis, at volume weighted average prices around 331–337 pence per share depending on venue and date.
After these transactions settle, Haleon’s registered share capital is 8,880,262,266 ordinary shares, of which 12,184,020 are held as treasury shares. The number of ordinary shares with voting rights is 8,868,078,246, a figure shareholders can use when assessing notification thresholds under the UK Disclosure Guidance and Transparency Rules.
Haleon plc reported the repurchase of 10,205,329 ordinary shares of £0.01 each for cancellation under its share buyback programme. The purchases took place between 05 May 2026 and 08 May 2026 across the London Stock Exchange, CBOE (UK) venues and Aquis, at volume weighted average prices around 331–337 pence per share depending on venue and date.
After these transactions settle, Haleon’s registered share capital is 8,880,262,266 ordinary shares, of which 12,184,020 are held as treasury shares. The number of ordinary shares with voting rights is 8,868,078,246, a figure shareholders can use when assessing notification thresholds under the UK Disclosure Guidance and Transparency Rules.
Haleon plc has published updated listing particulars for Haleon UK Capital plc’s and Haleon Netherlands Capital B.V.’s £10,000,000,000 Euro Medium Term Note (EMTN) Programme, which is guaranteed by Haleon. This is described as a routine annual update. The listing particulars, dated 7 May 2026, are available to download from Haleon’s investor debt section online.
The EMTN programme provides a framework under which the group can issue debt securities in the future, subject to applicable terms and investor eligibility set out in the listing particulars.
Haleon plc has published updated listing particulars for Haleon UK Capital plc’s and Haleon Netherlands Capital B.V.’s £10,000,000,000 Euro Medium Term Note (EMTN) Programme, which is guaranteed by Haleon. This is described as a routine annual update. The listing particulars, dated 7 May 2026, are available to download from Haleon’s investor debt section online.
The EMTN programme provides a framework under which the group can issue debt securities in the future, subject to applicable terms and investor eligibility set out in the listing particulars.
Haleon plc reported that it purchased 12,171,987 ordinary shares of £0.01 each for cancellation under its share buyback programme announced on 12 March 2026. The purchases were made between 27 April and 1 May 2026 across the London Stock Exchange, CBOE (UK) venues and Aquis.
After these transactions settle, Haleon’s registered share capital is 8,890,467,595 ordinary shares, of which 12,240,797 are held as treasury shares. The number of ordinary shares with voting rights is 8,878,226,798, which shareholders can use to assess notification thresholds under the FCA’s Disclosure Guidance and Transparency Rules.
Haleon plc reported that it purchased 12,171,987 ordinary shares of £0.01 each for cancellation under its share buyback programme announced on 12 March 2026. The purchases were made between 27 April and 1 May 2026 across the London Stock Exchange, CBOE (UK) venues and Aquis.
After these transactions settle, Haleon’s registered share capital is 8,890,467,595 ordinary shares, of which 12,240,797 are held as treasury shares. The number of ordinary shares with voting rights is 8,878,226,798, which shareholders can use to assess notification thresholds under the FCA’s Disclosure Guidance and Transparency Rules.
Haleon plc reports its share capital and voting rights position as at 30 April 2026. The company has issued a total of 8,891,932,595 ordinary shares of £0.01 each, with 12,240,797 held as treasury shares. As a result, 8,879,691,798 ordinary shares carry voting rights. Shareholders and other parties with notification obligations are instructed to use this voting-rights figure as the denominator when calculating whether they must notify their interest in Haleon under the FCA's Disclosure Guidance and Transparency Rules.
Haleon plc reports its share capital and voting rights position as at 30 April 2026. The company has issued a total of 8,891,932,595 ordinary shares of £0.01 each, with 12,240,797 held as treasury shares. As a result, 8,879,691,798 ordinary shares carry voting rights. Shareholders and other parties with notification obligations are instructed to use this voting-rights figure as the denominator when calculating whether they must notify their interest in Haleon under the FCA's Disclosure Guidance and Transparency Rules.
Haleon plc reported the results of its 2026 Annual General Meeting, confirming that all resolutions were approved by poll vote. Resolutions 20–23 were passed as special resolutions, with all others passed as ordinary resolutions.
Shareholders received the Annual Report & Accounts, with 7,518,381,689 votes in favour, and approved the Directors’ Remuneration Report and Remuneration Policy with support of 98.00% and 94.65% of votes cast, respectively. A final dividend was approved with 7,540,340,495 votes for and 0.01% against.
All directors standing for election or re-election were strongly supported, with backing generally above 99% of votes cast. Shareholders renewed authorities to allot ordinary shares and to disapply pre-emption rights, including an additional authority that received 92.78% support. Authority to purchase the Company’s own shares passed with 99.93% of votes cast.
Across resolutions, approximately 84.8% of the issued share capital was voted. As at 6:30pm BST on 24 April 2026, Haleon’s issued share capital was 8,903,405,354 ordinary shares, of which 12,281,053 were held as treasury shares, giving 8,891,124,301 total voting rights.
Haleon plc reported the results of its 2026 Annual General Meeting, confirming that all resolutions were approved by poll vote. Resolutions 20–23 were passed as special resolutions, with all others passed as ordinary resolutions.
Shareholders received the Annual Report & Accounts, with 7,518,381,689 votes in favour, and approved the Directors’ Remuneration Report and Remuneration Policy with support of 98.00% and 94.65% of votes cast, respectively. A final dividend was approved with 7,540,340,495 votes for and 0.01% against.
All directors standing for election or re-election were strongly supported, with backing generally above 99% of votes cast. Shareholders renewed authorities to allot ordinary shares and to disapply pre-emption rights, including an additional authority that received 92.78% support. Authority to purchase the Company’s own shares passed with 99.93% of votes cast.
Across resolutions, approximately 84.8% of the issued share capital was voted. As at 6:30pm BST on 24 April 2026, Haleon’s issued share capital was 8,903,405,354 ordinary shares, of which 12,281,053 were held as treasury shares, giving 8,891,124,301 total voting rights.
Haleon plc has made its Q1 2026 trading statement for the year ending 31 December 2026 available online. The full document can be accessed via a linked PDF and on the company’s investor relations website, and has also been submitted to the UK regulator’s National Storage Mechanism.
The company will host a short presentation and Q&A for analysts and shareholders at 9:00am BST on 29 April 2026, led by the Chief Executive Officer and Chief Financial Officer, with dial-in details provided for UK, US and other participants. An archived webcast of the Q&A will be available later the same day.
Haleon plc has made its Q1 2026 trading statement for the year ending 31 December 2026 available online. The full document can be accessed via a linked PDF and on the company’s investor relations website, and has also been submitted to the UK regulator’s National Storage Mechanism.
The company will host a short presentation and Q&A for analysts and shareholders at 9:00am BST on 29 April 2026, led by the Chief Executive Officer and Chief Financial Officer, with dial-in details provided for UK, US and other participants. An archived webcast of the Q&A will be available later the same day.
Haleon plc repurchased 8,444,107 ordinary shares of £0.01 each for cancellation under its share buyback programme announced on 12 March 2026.
The purchases took place on 20–24 April 2026 across the London Stock Exchange, CBOE (UK) BXE and CXE, and Aquis, at prices between 342.7000p and 357.1000p per share. Volume weighted average prices by venue ranged from about 345.6215p to 355.7028p per share.
After settlement, Haleon’s registered share capital is 8,902,639,582 ordinary shares, of which 12,281,053 are held as treasury shares. This leaves 8,890,358,529 ordinary shares with voting rights, a figure shareholders can use for UK disclosure threshold calculations.
Haleon plc repurchased 8,444,107 ordinary shares of £0.01 each for cancellation under its share buyback programme announced on 12 March 2026.
The purchases took place on 20–24 April 2026 across the London Stock Exchange, CBOE (UK) BXE and CXE, and Aquis, at prices between 342.7000p and 357.1000p per share. Volume weighted average prices by venue ranged from about 345.6215p to 355.7028p per share.
After settlement, Haleon’s registered share capital is 8,902,639,582 ordinary shares, of which 12,281,053 are held as treasury shares. This leaves 8,890,358,529 ordinary shares with voting rights, a figure shareholders can use for UK disclosure threshold calculations.
Haleon plc reported that it purchased 8,740,351 ordinary shares of £0.01 each for cancellation under its share buyback programme announced on 12 March 2026. The purchases took place between 13 and 17 April 2026 across the London Stock Exchange, CBOE (UK) BXE and CXE.
After settlement of these transactions, Haleon’s registered share capital is 8,911,083,689 ordinary shares, including 12,320,645 held as treasury shares. The number of ordinary shares with voting rights is now 8,898,763,044, which shareholders may use when assessing notification thresholds under UK disclosure rules.
Haleon plc reported that it purchased 8,740,351 ordinary shares of £0.01 each for cancellation under its share buyback programme announced on 12 March 2026. The purchases took place between 13 and 17 April 2026 across the London Stock Exchange, CBOE (UK) BXE and CXE.
After settlement of these transactions, Haleon’s registered share capital is 8,911,083,689 ordinary shares, including 12,320,645 held as treasury shares. The number of ordinary shares with voting rights is now 8,898,763,044, which shareholders may use when assessing notification thresholds under UK disclosure rules.
Haleon plc reported purchases of 7,740,513 ordinary shares of £0.01 each for cancellation under its share buyback programme announced on 12 March 2026. The shares were bought on multiple UK trading venues between 7 and 10 April 2026 at prices around the mid‑370p range.
After settlement, Haleon’s registered share capital is 8,919,824,040 ordinary shares, of which 12,439,998 are held as treasury shares. This leaves 8,907,384,042 ordinary shares with voting rights, a figure shareholders can use when assessing disclosure thresholds under the FCA’s transparency rules.
Haleon plc reported purchases of 7,740,513 ordinary shares of £0.01 each for cancellation under its share buyback programme announced on 12 March 2026. The shares were bought on multiple UK trading venues between 7 and 10 April 2026 at prices around the mid‑370p range.
After settlement, Haleon’s registered share capital is 8,919,824,040 ordinary shares, of which 12,439,998 are held as treasury shares. This leaves 8,907,384,042 ordinary shares with voting rights, a figure shareholders can use when assessing disclosure thresholds under the FCA’s transparency rules.